Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Baker

Showing results (631-640 of 1,278) with videos related to

Pageof 128
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 28, 2005
A model of anthrax toxin lethal factor bound to protective antigenD Borden Lacy, Henry C Lin, Roman A Melnyk, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry|October 26, 2017
Improved Free-Energy Landscape Quantification Illustrated with a Computationally Designed Protein-Ligand InteractionWilliam J Van Patten, Robert Walder, Ayush Adhikari, et al.
Plos One|September 9, 2017
Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years-The Australian Positive & Peers Longevity Evaluation Study (APPLES)Kathy Petoumenos, Robin Huang, Jennifer Hoy, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 12, 2005
UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disordersEva de Lago, Javier Fernández-Ruiz, Silvia Ortega-Gutiérrez, et al.
Scientific American|May 23, 2006
Engineering life: building a fab for biologyBio FAB Group, David Baker, George Church, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
The epigenetics of multiple sclerosis and other related disordersPeter J van den Elsen, Marja C J A van Eggermond, Fabiola Puentes, et al.
Biochemistry|March 3, 2004
Contributions of amino acid side chains to the kinetics and thermodynamics of the bivalent binding of protein L to Ig kappa light chainHenrik G Svensson, William J Wedemeyer, Jennifer L Ekstrom, et al.
Plos One|February 8, 2011
Heterologous epitope-scaffold prime:boosting immuno-focuses B cell responses to the HIV-1 gp41 2F5 neutralization determinantJavier Guenaga, Pia Dosenovic, Gilad Ofek, et al.
Social Psychiatry and Psychiatric Epidemiology|June 19, 2025
Psychological distress and mental health disparities over time between tertiary students and non-student working peers in AustraliaShu Mei Teo, Daniel Gan, Mengmeng Wang, et al.
Protein Science : a Publication of the Protein Society|December 17, 2019
Design and structure of two new protein cages illustrate successes and ongoing challenges in protein engineeringKevin A Cannon, Rachel U Park, Scott E Boyken, et al.
Pageof 128

Showing results (631-640 of 1,278) with videos related to

Sort By:
Pageof 128
Proceedings of the National Academy of Sciences of the United States of America|October 28, 2005
A model of anthrax toxin lethal factor bound to protective antigenD Borden Lacy, Henry C Lin, Roman A Melnyk, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry|October 26, 2017
Improved Free-Energy Landscape Quantification Illustrated with a Computationally Designed Protein-Ligand InteractionWilliam J Van Patten, Robert Walder, Ayush Adhikari, et al.
Plos One|September 9, 2017
Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years-The Australian Positive & Peers Longevity Evaluation Study (APPLES)Kathy Petoumenos, Robin Huang, Jennifer Hoy, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 12, 2005
UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disordersEva de Lago, Javier Fernández-Ruiz, Silvia Ortega-Gutiérrez, et al.
Scientific American|May 23, 2006
Engineering life: building a fab for biologyBio FAB Group, David Baker, George Church, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
The epigenetics of multiple sclerosis and other related disordersPeter J van den Elsen, Marja C J A van Eggermond, Fabiola Puentes, et al.
Biochemistry|March 3, 2004
Contributions of amino acid side chains to the kinetics and thermodynamics of the bivalent binding of protein L to Ig kappa light chainHenrik G Svensson, William J Wedemeyer, Jennifer L Ekstrom, et al.
Plos One|February 8, 2011
Heterologous epitope-scaffold prime:boosting immuno-focuses B cell responses to the HIV-1 gp41 2F5 neutralization determinantJavier Guenaga, Pia Dosenovic, Gilad Ofek, et al.
Social Psychiatry and Psychiatric Epidemiology|June 19, 2025
Psychological distress and mental health disparities over time between tertiary students and non-student working peers in AustraliaShu Mei Teo, Daniel Gan, Mengmeng Wang, et al.
Protein Science : a Publication of the Protein Society|December 17, 2019
Design and structure of two new protein cages illustrate successes and ongoing challenges in protein engineeringKevin A Cannon, Rachel U Park, Scott E Boyken, et al.
Pageof 128